Emerging involvement of CXCL13 in cancer development and progression

Area of Science:

• Immunology
• Oncology
• Molecular Biology

Background:

• CXCL13 (C-X-C motif chemokine ligand 13) and its receptor CXCR5 are key in B-cell trafficking and lymphoid organ structure.
• The CXCL13-CXCR5 axis plays a role in both inflammation and cancer.
• Understanding this axis is vital for cancer research.

Purpose of the Study:

• To review the molecular mechanisms and signaling of the CXCL13-CXCR5 axis.
• To examine the role of CXCL13-CXCR5 signaling in cancer hallmark acquisition.
• To highlight the CXCL13-CXCR5 axis as a potential cancer therapeutic target.

Main Methods:

• Literature review integrating biochemical, structural, and immunological data.
• Analysis of signaling pathways and regulatory feedback loops of CXCL13-CXCR5.
• Examination of the axis's contribution to cancer progression mechanisms.

Main Results:

• CXCL13-CXCR5 signaling influences angiogenesis, epithelial-mesenchymal transition, and metastatic niche formation.
• The axis contributes to tertiary lymphoid structures, impacting antitumor immunity.
• The axis is a critical link between lymphoid neogenesis and tumor evolution.

Conclusions:

• The CXCL13-CXCR5 axis is a significant mediator in cancer development and progression.
• Targeting the CXCL13-CXCR5 pathway presents a promising strategy for cancer therapy.
• Further research into this axis can advance our understanding of tumor immunology.